Ed Lecluyse

About Ed Lecluyse

Dr. LeCluyse is a Research Fellow in the Life Sciences Division at LifeNet Health in Research Triangle Park, NC. The focus of this program is to provide human tissues and cells to the academic and industrial research communities. He is also part of the research and development team that is focused on providing novel tools and cell culture models for basic and clinical research. Dr. LeCluyse completed his Ph.D. in Biochemistry at the University of Kansas, Lawrence campus, and postdoctoral training in Toxicology/Pharmacology at the University of Kansas Medical School. He served as senior research biologist at Merck & Co, Inc. and as an associate professor at the University of North Carolina-Chapel Hill School of Pharmacy. He was a Chief Scientific Officer at CellzDirect which became part of Invitrogen and Life Technologies. He joined the Hamner Institutes (CIIT) as a Principal Investigator until becoming part of LifeNet Health in 2016. He has published over 125 research articles, book chapters and review papers related to the biological, toxicological and pharmaceutical sciences.Specialties: In vitro hepatic model systems, primary hepatocyte isolation and culture methods, enzyme induction, DILI, in vitro toxicology

Experience

1. Research Fellow

   LifeNet Health

   Oct 2024 — Present

Education

• The University of Kansas

  Ph.D., Biochemistry

  1989 — 1994

• University of Kansas Medical Center

  Postdoctoral training, Pharmacology and Toxicology

  1995 — 1996

Skills

• Cell Biology
• Molecular Biology
• Pharmacology
• Cell Culture
• Drug Discovery
• Biomarkers
• Adme
• Lifesciences
• In Vitro Toxicology
• Life Sciences
• Biochemistry
• Clinical Development
• Cell
• Pharmaceutical Industry
• In Vitro
• Drug Metabolism
• Biotechnology
• Research and Development (R&D)
• Research
• Drug Development
• Assay Development
• Toxicology
• Clinical Trials
• Elisa